Cargando…

Commentary: Dexamethasone intravitreal implant therapy in Vogt–Koyanagi–Harada disease

Detalles Bibliográficos
Autores principales:	Kawali, Ankush, Srinivasan, Sanjay, Mahendradas, Padmamalini, Shetty, Rohit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426154/ https://www.ncbi.nlm.nih.gov/pubmed/35791136 http://dx.doi.org/10.4103/ijo.IJO_1207_22

Ejemplares similares

Commentary: Appraisal of histopathological correlations in Vogt-Koyanagi-Harada uveitis
por: Murugan, Sivaraman Bala
Publicado: (2019)

Intravitreal methotrexate and fluocinolone acetonide implantation for Vogt-Koyanagi-Harada uveitis
por: Park, Jong G., et al.
Publicado: (2020)

Commentary for distribution and risk factors of postoperative endophthalmitis in people with diabetes
por: Mahendradas, Padmamalini, et al.
Publicado: (2021)

Commentary: Sight-threatening intraocular infection in patients with COVID-19 in India
por: Mahendradas, Padmamalini, et al.
Publicado: (2021)

Commentary: Swept source optical coherence tomography: Nuances in Vogt-Koyanagi-Harada disease
por: Das, Dipankar, et al.
Publicado: (2022)

Efficacy of intravitreal dexamethasone implant in patients with Vogt–Koyanagi–Harada Disease and bilateral panuveitis: Two case reports
por: Chen, Po-Lin, et al.
Publicado: (2021)

Long-term efficacy of dexamethasone intravitreal implant in the treatment of Vogt-Koyanagi-Harada disease relapsing posterior uveitis
por: Elhamaky, Tarek R
Publicado: (2022)

Commentary: Evidence of dengue virus in eviscerated specimens of panophthalmitis secondary to dengue fever: A possible cause-effect phenomenon
por: Mahendradas, Padmamalini, et al.
Publicado: (2022)

Choroidal Vascularity Index in Vogt-Koyanagi-Harada Disease: An EDI-OCT Derived Tool for Monitoring Disease Progression
por: Agrawal, Rupesh, et al.
Publicado: (2016)

Role of intravitreal triamcinolone as an adjuvant in the management of Vogt-Koyanagi-Harada disease
por: Moreker, Mayur R, et al.
Publicado: (2007)

Rebound inflammation after an intravitreal injection in Vogt–Koyanagi–Harada syndrome
por: Ranjan, Richa, et al.
Publicado: (2018)

Treatment of Vogt-Koyanagi-Harada Disease
por: Alaql, Musab K, et al.
Publicado: (2020)

Tofacitinib in Vogt-Koyanagi-Harada disease
por: Dutta Majumder, Parthopratim, et al.
Publicado: (2020)

An Unusual Presentation of Vogt–Koyanagi–Harada
por: Ipek, Sefik Can, et al.
Publicado: (2021)

Vogt-Koyanagi-Harada Disease and COVID
por: Manni, Priscilla, et al.
Publicado: (2023)

The Use of Intravitreal Ranibizumab for Choroidal Neovascularization Associated with Vogt-Koyanagi-Harada Syndrome
por: Kolomeyer, A. M., et al.
Publicado: (2011)

Comment on: Rebound inflammation after an intravitreal injection in Vogt–Koyanagi–Harada syndrome
por: Jain, Manish
Publicado: (2018)

Topical interferon therapy in uveitic macular edema
por: Kawali, Ankush, et al.
Publicado: (2022)

Rituximab in refractory Vogt–Koyanagi–Harada disease
por: Dolz-Marco, Rosa, et al.
Publicado: (2011)

Choroidal Excavation in Vogt-Koyanagi-Harada Disease
por: Hashida, Noriyasu, et al.
Publicado: (2014)

Vogt-Koyanagi-Harada syndrome presenting with encephalopathy
por: Naeini, Alireza E., et al.
Publicado: (2014)

Vogt–Koyanagi–Harada syndrome – current perspectives
por: Baltmr, Abeir, et al.
Publicado: (2016)

Vogt-Koyanagi-Harada syndrome presenting with encephalopathy
por: Naeini, Alireza E., et al.
Publicado: (2013)

Initial misdiagnosis of Vogt-Koyanagi-Harada disease
por: Shoughy, Samir S., et al.
Publicado: (2019)

Unilateral Presentation of Vogt-Koyanagi-Harada Syndrome
por: Hosseini, Seyedeh Maryam, et al.
Publicado: (2020)

Miliary microaneurysms: An angiographic biomarker of leukemic retinopathy?
por: Kawali, Ankush, et al.
Publicado: (2020)

Lockdown effects on a patient receiving immunosuppression for unilateral HLA- B27 associated uveitis during COVID-19 pandemic
por: Sanjay, Srinivasan, et al.
Publicado: (2021)

Response to comment on: Rebound inflammation after an intravitreal injection in Vogt–Koyanagi–Harada syndrome
por: Ranjan, Richa, et al.
Publicado: (2018)

Adalimumab in Vogt-Koyanagi-Harada Disease Refractory to Conventional Therapy
por: Yang, Shizhao, et al.
Publicado: (2022)

Vogt–Koyanagi–Harada disease: headache as an initial manifestation
por: Tavsanli, Mustafa, et al.
Publicado: (2008)

Influence of molecular genetics in Vogt-Koyanagi-Harada disease
por: Ng, Joanne YW, et al.
Publicado: (2014)

Vogt-Koyanagi-Harada Syndrome following influenza vaccination
por: Kim, Moosang
Publicado: (2016)

Vogt-Koyanagi-Harada syndrome presenting with encephalopathy: Retraction
Publicado: (2015)

Presumed atypical peripapillary Vogt-Koyanagi-Harada disease
por: Abucham-Neto, Julio Zaki, et al.
Publicado: (2019)

Ocular syphilis mimicking Vogt–Koyanagi–Harada disease
por: Lin, Yu-Ching, et al.
Publicado: (2019)

Vogt-Koyanagi-Harada Syndrome - A Neurologist's Perspective
por: Shivaram, Sumanth, et al.
Publicado: (2021)

Tozinameran: Vogt-Koyanagi-Harada disease: case report
Publicado: (2022)

Vogt-Koyanagi-Harada disease following influenza vaccination
por: Murtaza, Fahmeeda, et al.
Publicado: (2022)

Vogt-Koyanagi-Harada Syndrome: A Diagnostic Conundrum
por: Hussain, Anila, et al.
Publicado: (2021)

Bibliometric analysis of the Vogt‒Koyanagi‒Harada disease literature
por: Li, Liangpin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jn3cka23pt2a3veu0pp669agbg